Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Catheter Precision Inc VTAK

Catheter Precision, Inc. is a medical device company. It is engaged in providing new solutions to the market to improve the treatment of cardiac arrhythmias. It is focused on developing technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products. It is also focused on developing and delivering electrophysiology products to provide... see more

Recent & Breaking News (NYSEAM:VTAK)

Catheter Precision, Inc. (NYSE-American:VTAK) Expands Sales Team; Expects Corresponding Rise in Revenue Over the Near Term; Anticipates Breakeven by End of Year

Accesswire April 4, 2024

Catheter Precision, Inc. (NYSE American:VTAK) Releases Operational Performance Report, Q4 and Annual 2023 Financials for Year Ending December 31, 2023

Accesswire April 1, 2024

Catheter Precision, Inc. (NYSE American:VTAK) to Sponsor the Monaco USA Arrhythmia Course

Accesswire March 19, 2024

Catheter Precision, Inc. (NYSE American:VTAK) Announces the First use of VIVO in Qatar

Accesswire March 14, 2024

Catheter Precision, Inc. (NYSE American: VTAK) Announces the First use of LockeT Outside of the United States

Accesswire March 11, 2024

Catheter Precision, Inc. (NYSE American:VTAK) Announces the First Use of VIVO With a Pediatric Patient in Turkey

Accesswire February 28, 2024

Catheter Precision, Inc. (NYS American:VTAK) Announces Attendance at the International Symposium on Left Atrial Appendage

Accesswire February 26, 2024

Catheter Precision, Inc. Announces the Presentation of the First Clinical Data on LockeT

Accesswire February 22, 2024

Catheter Precision, Inc. Participates in AF Symposium

Accesswire January 29, 2024

Catheter Precision, Inc. (VTAK) Secures New Distributor for VIVO in Turkey

Accesswire January 25, 2024

Catheter Precision, Inc. (NYSE American:VTAK) Presenting at the Sequire Investor Summit in Puerto Rico

Accesswire January 22, 2024

Catheter Precision, Inc. (VTAK) Secures New Distributor in Brazil for LockeT

Accesswire January 22, 2024

Catheter Precision's VIVO System Featured in Electrophysiology Publication

Accesswire January 17, 2024

CORRECTION: Catheter Precision, Inc.'s (VTAK) Board Authorizes its CEO and Chairman to Make "Open Market" Purchases of Company Shares

Accesswire January 11, 2024

Cather Precision, Inc.'s (VTAK) Board Authorizes its CEO and Chairman to Make "Open Market" Purchases of Company Shares

Accesswire January 11, 2024

CATHETER PRECISION, INC. (VTAK) Reports Unaudited Preliminary Fourth Quarter and Full Year 2023 Results

Accesswire January 10, 2024

Catheter Precision, Inc. (VTAK) Announces Changes to Executive Management and Board of Directors

Accesswire January 3, 2024

Catheter Precision, Inc. (VTAK) Receives Additional Patents for LockeT in Great Britain and the European Market

Accesswire January 2, 2024

Catheter Precision, Inc. Reports Third Quarter Results of Operations and Filing of Third Quarter 10-Q

Accesswire December 22, 2023

CATHETER PRECISION, INC. Reports Filing of 10-Q and Second Quarter Results of Operations

Accesswire December 18, 2023